Jang Mi-Ae, Chung Jong-Won, Yeon Je Young, Kim Jong-Soo, Hong Seung Chyul, Bang Oh Young, Ki Chang-Seok
Department of Laboratory Medicine and Genetics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Department of Neurology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
PLoS One. 2017 Jun 15;12(6):e0179689. doi: 10.1371/journal.pone.0179689. eCollection 2017.
Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by stenosis of the internal carotid arteries with compensatory development of collateral vessels. Although a founder variant of RNF213, p.Arg4810Lys (c.14429G>A, rs112735431), is a major genetic risk factor for MMD in East Asians, the frequency and disease susceptibility of other variants in this gene remain largely unknown. In the present study, we investigated the association of RNF213 variants with MMD in Korean patients and population controls.
For all RNF213 variants listed in the Human Gene Mutation Database (HGMD) as disease-causing or likely disease-causing mutations for MMD, genotyping was performed using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Genetic data from 264 adult patients with MMD were analyzed and compared with two control populations comprised of 622 and 1,100 Korean individuals, respectively.
Among the 30 RNF213 variants that were listed in the HGMD, p.Arg4810Lys was identified in 67.4% (178/264) of patients with MMD and showed a significantly higher allele frequency than in the controls, giving an odds ratio of 63.29 (95% confidence interval, 33.11-120.98) for the 622 controls and 48.55 (95% confidence interval, 31.00-76.03) for the 1100 controls. One additional variant, p.Ala5021Val (c.15062C>T, rs138130613), was identified in 0.8% (2/264) of patients; however, the allele frequencies were not significantly different from those in the controls.
These results suggest that, in our cohort of Korean patients, the p.Arg4810Lys is the only variant that is strongly associated with MMD among the 30 RNF213 variants listed in the HGMD.
烟雾病(MMD)是一种罕见的脑血管疾病,其特征为颈内动脉狭窄并伴有代偿性侧支血管形成。虽然RNF213基因的一个始祖变异体p.Arg4810Lys(c.14429G>A,rs112735431)是东亚人群烟雾病的主要遗传危险因素,但该基因其他变异体的频率及疾病易感性仍大多未知。在本研究中,我们调查了韩国烟雾病患者和人群对照中RNF213变异体与烟雾病的关联。
对于《人类基因突变数据库》(HGMD)中列为烟雾病致病或可能致病突变的所有RNF213变异体,采用基质辅助激光解吸/电离飞行时间质谱法进行基因分型。分析了264例成年烟雾病患者的遗传数据,并与分别由622名和1100名韩国个体组成的两个对照人群进行比较。
在HGMD列出的30个RNF213变异体中,67.4%(178/264)的烟雾病患者中检测到p.Arg4810Lys,其等位基因频率显著高于对照组,在622名对照人群中的比值比为63.29(95%置信区间,33.11 - 120.98),在1100名对照人群中的比值比为48.55(95%置信区间,31.00 - 76.03)。另外一个变异体p.Ala5021Val(c.15062C>T,rs138130613)在0.8%(2/264)的患者中被检测到;然而,其等位基因频率与对照组无显著差异。
这些结果表明,在我们的韩国患者队列中,p.Arg4810Lys是HGMD列出的30个RNF213变异体中唯一与烟雾病密切相关的变异体。